This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2013 Jul;33(7):1909-10.

doi: 10.1007/s00296-012-2409-1. Epub 2012 Mar 24.

Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis

César Faillace, Jozélio Freire de Carvalho

PMID: 22441966
DOI: 10.1007/s00296-012-2409-1

Case Reports

Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis

César Faillace et al. Rheumatol Int. 2013 Jul.

. 2013 Jul;33(7):1909-10.

doi: 10.1007/s00296-012-2409-1. Epub 2012 Mar 24.

Authors

César Faillace, Jozélio Freire de Carvalho

PMID: 22441966
DOI: 10.1007/s00296-012-2409-1

No abstract available

PubMed Disclaimer

Similar articles

Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.
Salgado E, Campos J, Moreira-Navarrete V, Mulero J, Navarro F, Pérez-Pampín E, Carmona L, Gómez-Reino J. Salgado E, et al. Joint Bone Spine. 2013 Jul;80(4):438-40. doi: 10.1016/j.jbspin.2013.01.004. Epub 2013 Mar 1. Joint Bone Spine. 2013. PMID: 23453477 No abstract available.
Increased levels of rheumatoid factors after TNF inhibitor in rheumatoid arthritis.
Mendonça JA, Marques-Neto JF, Samara AM, Appenzeller S. Mendonça JA, et al. Rheumatol Int. 2012 Mar;32(3):815-8. doi: 10.1007/s00296-011-1812-3. Epub 2011 Feb 15. Rheumatol Int. 2012. PMID: 21327431
Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre.
Addimanda O, Possemato N, Macchioni P, Salvarani C. Addimanda O, et al. Clin Exp Rheumatol. 2014 Jul-Aug;32(4):460-4. Epub 2014 Jun 23. Clin Exp Rheumatol. 2014. PMID: 24960220
CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
Inoue A, Sawada Y, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Nishio D, Nakamura M. Inoue A, et al. Acta Derm Venereol. 2016 May;96(4):570-1. doi: 10.2340/00015555-2309. Acta Derm Venereol. 2016. PMID: 26631390 Review. No abstract available.
IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS, Ruderman EM. Woodrick RS, et al. Bull NYU Hosp Jt Dis. 2012;70(3):195-9. Bull NYU Hosp Jt Dis. 2012. PMID: 23259628 Review.

See all similar articles

Cited by

Rheumatoid factors: clinical applications.
Ingegnoli F, Castelli R, Gualtierotti R. Ingegnoli F, et al. Dis Markers. 2013;35(6):727-34. doi: 10.1155/2013/726598. Epub 2013 Nov 13. Dis Markers. 2013. PMID: 24324289 Free PMC article. Review.
Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.
van Schie KA, Wolbink GJ, Rispens T. van Schie KA, et al. MAbs. 2015;7(4):662-71. doi: 10.1080/19420862.2015.1048411. MAbs. 2015. PMID: 25962087 Free PMC article. Review.

References

1. Best Pract Res Clin Rheumatol. 2008 Oct;22(5):847-61 - PubMed
1. Curr Opin Rheumatol. 2003 May;15(3):267-73 - PubMed
1. Joint Bone Spine. 2009 May;76(3):248-53 - PubMed
1. Rev Bras Reumatol. 2010 May-Jun;50(3):225-34 - PubMed
1. Ann Rheum Dis. 2004 Oct;63(10):1218-21 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program